Wall Street closes higher, Nasdaq sets record as potential vaccines show promise
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Morgan Stanley Reiterates Equalweight Rating on Pfizer (PFE) Following COVID Vaccine Update
July 21, 2020 8:42 AM EDTMorgan Stanley analyst David Risinger reiterated an Equalweight rating and $36.00 price target on Pfizer (NYSE: PFE) following the company's COVID vaccine update. Results appear encouraging vs. MRNA and AZN, but x-trial comps are confounded.
Risinger await results from BNT162b2(full spike)... More
Amazon (AMZN) Hovers Near Session High, Up 7%
July 20, 2020 2:55 PM EDTAmazon (NASDAQ: AMZN) Hovers Near Session High, Up 7%
... MoreTesla (TSLA) adds to gains, shares now up 8.2%
July 20, 2020 1:43 PM EDTTesla (NASDAQ: TSLA) adds to gains, shares now up 8.2%
... MoreAmazon (AMZN) Continues to Outperform Major Indexes, Up 4.75% to $3,100
July 20, 2020 11:30 AM EDTAmazon (NASDAQ: AMZN) Continues to Outperform Major Indexes, Up 4.75% to $3,100
Mizuho 'Encouraged' by Pfizer (PFE) COVID-19 Vaccine Data
July 20, 2020 10:57 AM EDTMizuho Securities analyst Vamil Divan reiterated a Buy rating and $38.00 price target on Pfizer (NYSE: PFE), citing continued positive progress on its COVID vaccine.
The analyst commented, "We are encouraged by new data from Pfizer and partner BioNTech on the progress they are... More
Amazon.com (AMZN) PT Raised to $3,350 at MKM Partners
July 20, 2020 8:15 AM EDTMKM Partners analyst Rohit Kulkami raised the price target on Amazon.com (NASDAQ: AMZN) to $3,350.00 (from $2,525.00) while maintaining a Buy rating.
The analyst comments "We are increasing our 2020 and 2021 Revenue & EPS estimates (again). Our 2021 Revenue estimates are now 8% above pre-Covid levels, but... More
